Still no weight loss at week 4 on Mounjaro? Here's what the evidence says

Week 4: you're still on the starter dose, and that's by design

Picture this: you pull your Mounjaro pen from the fridge door on your fourth injection morning, jab it in as you've done before, and later step on the scales expecting something. Nothing. Maybe a pound, maybe nothing at all. Before anything else, it helps to know what 2.5mg is actually for.

The first pen of Mounjaro isn't a therapeutic dose in the weight-loss sense. It's a settling-in period, calibrated so your digestive system has time to get used to a dual GIP and GLP-1 receptor agonist before a meaningful dose begins. Nausea, the most common early side effect, tends to be worst at this stage, and managing it is part of the reason the schedule starts low. The NHS's tirzepatide medicine guide explains this tolerability purpose clearly. So if you started Mounjaro four weeks ago and weight loss feels absent, you may simply be measuring the wrong phase.

That said, some people do notice a small shift in week four, appetite tends to reduce before the scales reflect it, and water-retention changes can mask real fat loss on any given day. Weighing yourself at the same time of day, once a week, gives a cleaner picture than daily readings.

What the trial data actually shows about early weeks

The SURMOUNT-1 trial (which followed around 2,500 adults with obesity over 72 weeks) recorded average weight reduction of roughly 20–21% at the 15mg dose, but that figure is the end of a long curve, not a week-four snapshot. Published in the New England Journal of Medicine, the data shows weight loss building progressively through titration, with the steepest reductions typically occurring once higher doses are reached and sustained.

Most participants were titrated upward every four weeks. The implication for someone at week four is straightforward: the pharmacological conditions for meaningful weight loss are still being established. Your dose is about to increase, or has just increased, and the metabolic changes that follow a higher dose take a few weeks to translate into scale movement.

It's also worth checking whether non-weight signals are shifting. Hunger between meals, portion size, cravings for high-calorie food, these often change before bodyweight does. If appetite is starting to settle, that's consistent with the medicine doing what it's supposed to do. For a broader look at how weight loss typically progresses on Mounjaro, and what a realistic timeline looks like across doses, there's a dedicated page on the topic.

When lack of progress needs a clinical conversation

There's a difference between early slowness that resolves with titration, and a genuine plateau that warrants clinical input. A few things are worth knowing.

Side effects that make eating uncomfortable (persistent nausea, reflux, fatigue) can actually suppress calories without triggering scale movement if they're also suppressing activity or causing dehydration. If you're feeling unwell, that's a conversation for your prescriber, not something to push through alone. The MHRA's Yellow Card scheme exists for reporting unexpected or severe reactions.

If you're a transfer patient who has come across to nume from another provider and arrived at week four already on a higher dose, the picture is different, your prescriber will want to see evidence of your existing treatment history before any dose review.

For people who've been at this for longer than four weeks and are still seeing nothing, there's more detailed guidance on persistent lack of weight loss on Mounjaro that covers what the clinical evidence says about non-responders, and when reviewing treatment is appropriate. And if you're wondering whether earlier weeks are where things went off course, the week 3 experience is covered separately, as is what typically happens if the scales aren't moving in week 2.

Practical steps while you wait for titration to take effect

A handful of things influence whether Mounjaro works as well as it can, and they're within your control.

Protein adequacy matters more on GLP-1 treatment than off it. When appetite falls, people often eat less of everything, including the protein that protects muscle mass during weight loss. NHS nutrition guidance recommends prioritising protein and fibre at each meal, especially when portions are smaller. Staying hydrated is also important; GI side effects can quietly tip into dehydration if fluid intake drops alongside food intake.

Activity is the other piece. The medicine doesn't require you to suddenly train for a marathon, but keeping moving (even walking) supports the metabolic shift that Mounjaro is creating. Resistance activity, where possible, helps preserve lean mass as fat is lost.

On cost: if you're wondering whether the pace of results justifies the investment, what Mounjaro costs privately and what that price includes is explained openly. At nume, treatment pricing covers your consultation, clinical review and next-working-day delivery, no separate prescription fee, no subscription. But the bigger point is that four weeks, at a starter dose, isn't a fair test of the medicine. If you want to understand what weight loss in week 1 typically looks like, and why that first week sets the tone for the weeks that follow, there's a dedicated page covering it.

If you have questions about your treatment or want a clinical eye on where you are, check your eligibility and speak to our prescribers. A real clinician reviews every consultation the same day.